{"transactions":[{"id":838101,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2026-03-17T23:30:18.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":13334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":6666,"derivative":{"underlying":"Common Stock","underlying_shares":13334},"source":{"system":"sec-edgar","filing":"0001670138-26-000005","document":"form4-03172026_070309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000005/form4-03172026_070309.xml","form_type":"4"}},{"id":838100,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:18.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":7287,"price":91.9779,"value":670242.9573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units."}],"balance_after":18864,"source":{"system":"sec-edgar","filing":"0001670138-26-000005","document":"form4-03172026_070309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000005/form4-03172026_070309.xml","form_type":"4"}},{"id":838099,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:18.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":26151,"source":{"system":"sec-edgar","filing":"0001670138-26-000005","document":"form4-03172026_070309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000005/form4-03172026_070309.xml","form_type":"4"}},{"id":927030,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2026-01-30T23:30:10.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001670138-26-000003","document":"form4-01302026_060106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000003/form4-01302026_060106.xml","form_type":"4"}},{"id":927029,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-30T23:30:10.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":11760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":11760,"derivative":{"underlying":"Common Stock","underlying_shares":11760},"source":{"system":"sec-edgar","filing":"0001670138-26-000003","document":"form4-01302026_060106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000003/form4-01302026_060106.xml","form_type":"4"}},{"id":927028,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T23:30:10.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":18140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 28, 2026 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":18140,"derivative":{"exercise_price":100.85,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":18140},"source":{"system":"sec-edgar","filing":"0001670138-26-000003","document":"form4-01302026_060106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000003/form4-01302026_060106.xml","form_type":"4"}},{"id":932399,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-23T22:30:13.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":6666,"derivative":{"underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001670138-26-000002","document":"form4-01232026_050108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000002/form4-01232026_050108.xml","form_type":"4"}},{"id":932398,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:13.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":1822,"price":93.3252,"value":170038.5144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":12817,"source":{"system":"sec-edgar","filing":"0001670138-26-000002","document":"form4-01232026_050108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000002/form4-01232026_050108.xml","form_type":"4"}},{"id":932397,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:13.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":3334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":14639,"source":{"system":"sec-edgar","filing":"0001670138-26-000002","document":"form4-01232026_050108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000002/form4-01232026_050108.xml","form_type":"4"}},{"id":934313,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-21T21:05:09.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001670138-26-000001","document":"form4-01212026_040103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000001/form4-01212026_040103.xml","form_type":"4"}},{"id":934312,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-21T21:05:09.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":6911,"price":90.2696,"value":623853.2056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":11305,"source":{"system":"sec-edgar","filing":"0001670138-26-000001","document":"form4-01212026_040103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000001/form4-01212026_040103.xml","form_type":"4"}},{"id":934311,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-21T21:05:09.000Z","date":"2026-01-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":18216,"source":{"system":"sec-edgar","filing":"0001670138-26-000001","document":"form4-01212026_040103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000167013826000001/form4-01212026_040103.xml","form_type":"4"}},{"id":1296439,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T22:55:05.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-001954","document":"form4-01232025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001954/form4-01232025_100156.xml","form_type":"4"}},{"id":1296438,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T22:55:05.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 21, 2025 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":40000,"derivative":{"exercise_price":47.98,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-001954","document":"form4-01232025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001954/form4-01232025_100156.xml","form_type":"4"}},{"id":1298838,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-21T21:21:33.000Z","date":"2025-01-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-25-001779","document":"form4-01212025_090130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001779/form4-01212025_090130.xml","form_type":"4"}},{"id":1298837,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-21T21:21:33.000Z","date":"2025-01-17","kind":"sale","planned":false,"acquired":false,"shares":6969,"price":45.86,"value":319598.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":5649,"source":{"system":"sec-edgar","filing":"0001415889-25-001779","document":"form4-01212025_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001779/form4-01212025_090130.xml","form_type":"4"}},{"id":1298836,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-21T21:21:33.000Z","date":"2025-01-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":12618,"source":{"system":"sec-edgar","filing":"0001415889-25-001779","document":"form4-01212025_090130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001779/form4-01212025_090130.xml","form_type":"4"}},{"id":1365195,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-14T21:37:08.000Z","date":"2024-11-08","kind":"grant","planned":false,"acquired":true,"shares":118,"price":21.046,"value":2483.428,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 118 shares by the Reporting Person on November 8, 2024 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":118,"source":{"system":"sec-edgar","filing":"0001415889-24-026873","document":"form4-11142024_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924026873/form4-11142024_091104.xml","form_type":"4"}},{"id":1676464,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2024-01-19T00:42:11.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 16, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-24-001561","document":"form4-01192024_120106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001561/form4-01192024_120106.xml","form_type":"4"}},{"id":1676463,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T00:42:11.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option will vest one year after January 16, 2024 (the \"Vesting Commencement Date\") and the balance of the shares will vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":75000,"derivative":{"exercise_price":26.72,"expiration_date":"2034-01-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-001561","document":"form4-01192024_120106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001561/form4-01192024_120106.xml","form_type":"4"}},{"id":3969929,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-04T17:18:58.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on April 14, 2016 and the remaining shares vest in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date."}],"balance_after":22256,"derivative":{"exercise_price":2.06,"expiration_date":"2025-09-22","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-18-023804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919118023804/doc4.xml","form_type":"4"}},{"id":3969928,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-04T17:18:58.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":4000,"price":10,"value":40000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-023804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919118023804/doc4.xml","form_type":"4"}},{"id":3969927,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-04T17:18:58.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":4000,"price":2.06,"value":8240.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-18-023804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919118023804/doc4.xml","form_type":"4"}},{"id":3992669,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T20:16:11.000Z","date":"2018-03-14","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 48 months measured from March 14, 2018 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":60000,"derivative":{"exercise_price":9.5,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-020445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919118020445/doc4.xml","form_type":"4"}},{"id":4386449,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-14T19:37:20.000Z","date":"2017-03-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 48 months measured from March 9, 2017 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":30000,"derivative":{"exercise_price":11.75,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-020655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919117020655/doc4.xml","form_type":"4"}},{"id":4602621,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":59996,"kind":"person","name":"Quan Joanne","position":1,"cik":"0001670138","reported_name":"Quan Joanne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-15T14:58:01.000Z","date":"2016-03-23","kind":"grant","acquired":true,"shares":53452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the option shares on March 23, 2017 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant was approved by Issuer's board of directors on March 22, 2016, subject to stockholder approval of an amendment to the Issuer's 2013 Equity Incentive Plan (the \"Plan\") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016."}],"balance_after":53452,"derivative":{"exercise_price":15.89,"expiration_date":"2026-03-23","underlying":"Common Stock","underlying_shares":53452},"source":{"system":"sec-edgar","filing":"0001209191-16-141548","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670138/000120919116141548/doc4a.xml","form_type":"4/A","original_submission_date":"2016-03-28"}}]}